ATXN2 and amyotrophic lateral sclerosis: Pathologically, ALS patients with an ATXN2 intermediate RE show a significant loss in Purkinje cells in the cerebellar vermis [45] and, more remarkably, significantly greater amounts of phosphorylated TDP-43 in the spinal cord [46] than sporadic patients.